Faron Pharmaceuticals Oy (LON:FARN) Trading Down 12.9% – Here’s What Happened

Faron Pharmaceuticals Oy (LON:FARN) shares traded down 12.9% during mid-day trading on Wednesday . The company traded as low as GBX 39.55 and last traded at GBX 39.55. 135,842 shares were traded during trading, a decline of 16% from the average session volume of 161,651 shares. The stock had previously closed at GBX 45.40.

Faron Pharmaceuticals Oy Trading Down 9.8%

The firm has a market capitalization of £49.29 million, a price-to-earnings ratio of -1.77 and a beta of 1.18. The business’s 50-day moving average price is GBX 48.18 and its 200 day moving average price is GBX 132.14. The company has a debt-to-equity ratio of -133.35, a current ratio of 0.84 and a quick ratio of 1.09.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.